Misfolded α-synuclein (A-syn) is widely recognized as the primal cause of neurodegenerative diseases including Parkinson's disease and dementia with Lewy bodies. The normal cellular function of A-syn has, however, been elusive. There is evidence that A-syn plays multiple roles in the exocytotic pathway in the neuron, but the underlying molecular mechanisms are unclear. A-syn has been known to interact with negatively charged phospholipids and with vesicle SNARE protein VAMP2. Using single-vesicle docking/fusion assays, we find that A-syn promotes SNARE-dependent vesicles docking significantly at 2.5 μM. When phosphatidylserine (PS) is removed from t-SNARE-bearing vesicles, the docking enhancement by A-syn disappears and Asyn instead acts as an inhibitor for docking. In contrast, subtraction of PS from the v-SNAREcarrying vesicles enhances vesicle docking even further. Moreover, when we truncate the Cterminal 45 residues of A-syn that participates in interacting with VAMP2, the promotion of vesicle docking is abrogated. Thus, the results suggest that the A-syn's interaction with v-SNARE through its C-terminal tail and its concurrent interaction with PS in trans through its amphipathic N-terminal domain facilitate SNARE complex formation, whereby A-syn aids SNARE-dependent vesicle docking.
Introduction
α-Synuclein (A-syn) is a small presynaptic protein of vaguely defined normal function [1] .
But its medical implication is colossal because its misfolded products are the prime suspect of causing synucleinopathies including Parkinson's disease and dementia with Lewy bodies [2] [3] [4] . Several missense mutations and gene multiplications are often found to bring about the early onset of the familial Parkinson's disease [5] [6] [7] [8] [9] . Moreover, A-syn is a major component of the abnormal deposits found in the patients' brains [10] [11] [12] .
As inferred from its abundant presence at the presynapse [13, 14] , there is evidence that normal A-syn is broadly involved in vesicle trafficking pathways. Deletion of A-syn in pGEX-KG vector as N-terminal glutathione S-transferase (GST) fusion proteins. Full-length rat synaptotagmin-1 (syt1, amino acids 50-421, four native cysteines C74, C75, C77, and C79 were replaced by alanines and another C82 was replaced by serine) was inserted into pET-28b vector as a C-terminal His-tagged protein. All DNA sequences were confirmed by the Iowa State University DNA Sequencing Facility.
Protein expression and purification
Recombined proteins were expressed and purified as recently described [38, 39] . Briefly, all recombinant proteins were expressed in Escherichia coli BL21 (DE3) by growing the cells to OD 600 of 0.6-0.8 at 37°C, and then the cells were induced with 0.5 mM IPTG (isopropyl β-D-1-thiogalactopyranoside) at 18°C for 16 h. The cells were harvested and resuspended in PBS or PBS with 0.2% (w/v) Triton X-100 (PBST) for membrane proteins, supplemented with 1 mM AEBSF [4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride]. After sonication, the cell lysate was centrifuged at 15 000 rpm for 40 min using a Beckman JA-25.50 rotor. For GST-tagged proteins, syntaxin 1a, SNAP-25, VAMP2, A-syn, and Asyn_1-95, the supernatants were bound to Glutathione Agarose beads (Sigma-Aldrich). After thoroughly washing, recombined proteins were cleaved from beads with thrombin (0.02 unit μl −1 , Sigma-Aldrich) in PBS or PBS with 0.8% (w/v) octyl β-D-glucopyranoside (PBS-OG) for membrane proteins. For the His-tagged protein syt1, the supernatant was bound to Ni-NTA agarose beads (Qiagen), and the sample was eluted with buffer containing 25 mM HEPES-KOH (pH 7.4), 400 mM KCl, 250 mM imidazole, 0.8% OG, and 1 mM EDTA after washing.
Gel filtration and western blotting
To characterize the property of recombinant A-syn, the thrombin-cleaved A-syn was subjected to gel filtration chromatography on 10/300 GL Superdex 200 column (GE healthcare) using the biologic Duoflow system (Bio-Rad). The monomeric A-syn was collected and confirmed by another gel filtration. The elution volume of A-syn was determined using standard molecular mass markers (thyroglobulin, 670 kDa; γ-globulin, 158 kDa; ovalbumin, 44 kDa; myoglobin, 17 kDa; and vitamin B12, 1.35 kDa; Bio-Rad) on the same column. Western blotting of A-syn was carried out as previously described [39] .
Lipid mixture preparation
The lipid molecules used in the present study are 1,2-dioleoyl-sn-glycero-3-phospho-Lserine (DOPS), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), phosphatidylinositol-4,5-bisphosphate (PIP 2 , from porcine brain), cholesterol, and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamin-N-(biotinyl) (biotin-DPPE). All lipids were obtained from Avanti Polar Lipids. 1,1′-Dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI), 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindodicarbocyanine perchlorate (DiD), and sulforhodamine B were obtained from Invitrogen. The desired amounts of lipids were mixed in a glass tube. The mixture was first dried under the nitrogen flow to form a thin lipid film on the well of tube and then completely dried under vacuum.
Proteoliposome reconstitution
To mimic a favorable charge distribution for Ca 2+ -triggered vesicle fusion as described previously [40] , the molar ratios of lipids were set at 15: 62: 20: 2: 1: 0.1 (DOPS: POPC: cholesterol: PIP 2 : DiD: Biotin-DPPE) for the t-SNARE-reconstituted (t-) vesicles and 5: 74: 20: 1 (DOPS: POPC: cholesterol: DiI) for the v-SNARE-reconstituted (v-) vesicles. For the t-and v-vesicles with 20% PS or without DOPS, PIP 2 was replaced with an equal amount of POPC, and equivalent amounts of POPC were removed or added to the lipid mixture. For the single-vesicle docking assay, the proteoliposome reconstitution was performed following the procedure described recently [38] . Briefly, the completely dried lipid film was hydrated with dialysis buffer (25 mM HEPES (pH 7.4) and 100 mM KCl). After five freeze-thaw cycles, the protein-free large unilamellar vesicles (~100 nm in diameter) were prepared by extrusion through a 100 nm polycarbonate filter (Whatman) for at least 30 times. To make tvesicles, preassembled t-SNAREs (syntaxin: SNAP-25 = 1: 1.5) were mixed with proteinfree vesicles at the protein to lipid molar ratio of 1: 200 for syntaxin 1A (this ratio was kept for all experiments including the single-vesicle content-mixing assay) in the presence of 0.8% OG in the dialysis buffer at 4°C for 15 min. The liposome/protein mixture was diluted two times with dialysis buffer for t-vesicles, and then the diluted t-vesicles were dialyzed in 2 liters of dialysis buffer at 4°C overnight. The v-vesicles were prepared by following the same procedure with VAMP2 or the mixture of VAMP2 and syt1. For v-vesicles with syt1, the mixture was diluted twice with dialysis buffer containing 1 mM EDTA and dialyzed in 2 liters of dialysis buffer with EDTA at 4°C overnight.
Proteoliposomes for the single-vesicle content-mixing assay, using the small sulforhodamine B (SRB) content indicator, were prepared as described in our recent work [38, 41] . Briefly, the lipid compositions were the same as those used in the single-vesicle docking assay with the asymmetric charge distribution, except that the fluorescent lipid dyes (DiI and DiD) were replaced by the equal amount of POPC. The proteoliposome reconstitution was the same as that used for the single-vesicle docking assay, but the dried lipid film, intended for vvesicles, was hydrated in the presence of 20 mM SRB which was kept throughout the sample preparation steps prior to the dialysis overnight. Remaining free SRB was removed using the PD-10 desalting column (GE healthcare) after dialysis.
Single-molecule total internal reflection fluorescence microscope setup
The single-vesicle docking/fusion assays were carried out on the prism-type TIRF (total internal reflection fluorescence) microscope as described in our recent work [38] . Briefly, a 532 nm laser was used to excite the DiI-labeled v-vesicles and measure FRET, and a 635 nm laser was used to check the presence of the DiD-labeled t-vesicles. The movies were analyzed by smCamera (kindly provided by the Dr Taekjip Ha's group) and the Matlab programs developed in our laboratory to calculate the ratio of docked v-vesicles to immobilized t-vesicles.
Single-vesicle docking assay
The single-vesicle docking assay was described recently with some modifications [38] . The t-vesicles with the final lipid concentration of 1 μM were flown into the chamber and immobilized on the PEG-coated surface through the streptavidin-to-biotin lipid conjugation.
After 30-min incubation at room temperature (~25°C), the unbound t-vesicles were removed by two rounds of washing with 200 μl of dialysis buffer. The v-vesicles (3 μM) with or without A-syn were flown into the chamber and the sample was incubated for another 30 min at 37°C. After washing off free v-vesicles using dialysis buffer containing A-syn or equal volume of dialysis buffer, movies were acquired by taking 100 consecutive frames with the 100 ms exposure time from five randomly chosen imaging areas. The first 60 frames were taken using 532 nm laser excitation for DiI-labeled v-vesicles, and these data were used to calculate the FRET efficiency, while the final 40 frames were taken by using 635 nm laser excitation to verify the presence of DiD-labeled t-vesicles. The nonspecifically bound v-vesicles were excluded from the analysis.
Single-vesicle content-mixing assay
The modified single-vesicle docking assay was described recently [38] . The t-SNARE vesicles (100 μM) were immobilized on the PEG-coated surface through the streptavidin-tobiotin lipid conjugation for 20 min. Unbound t-vesicles were washed off by several rounds of washing with 200 μl of dialysis buffer. The v-vesicles (with syt1), in the presence of 1 mM EDTA (10 μM) with or without A-syn, were injected into the flow chamber, and the sample was incubated at room temperature for 10 min. Then, the unbound v-vesicles were washed out with the dialysis buffer with or without A-syn, supplemented with 1 mM EDTA, and the samples were incubated for the additional 20 min, followed by the injection of 500 μM Ca 2+ using the motorized syringe pump. Movies were acquired using the same TIRF setup as described above with 532 nm excitation for SRB, and the stepwise jump in the fluorescence emission intensity due to fluorescence dequenching of SRB was recorded as the signal for content mixing. TIRF microscope imaging and the data analysis of the singlevesicle content-mixing assay were described in detail elsewhere [42] .
Results

Recombinant A-syn is predominantly monomeric
There has been controversy surrounding whether normal, non-aggregated A-syn is a monomer or a tetramer [43] [44] [45] . Recently, a consensus has been built around that it exists predominantly as an intrinsically disordered monomer although the transient presence of a metastable tetramer cannot be ruled out [46] . We confirm with gel filtration that our purified, recombinant A-syn behaves similar to a native A-syn purified from the mouse brain ( Figure  1B ) [46] . We, however, observe a small population of SDS-resistant oligomers in western blot ( Figure 1B) , similar to what was reported before [47] . But we do not detect the higherorder oligomers reminiscent of the dopamine-induced aggregation [34, 48, 49] .
Low-level A-syn promotes SNARE-dependent vesicle docking
It was proposed by Burre et al. [31] that A-syn promotes SNARE complex formation. To investigate the mechanism whereby A-syn promotes SNARE assembly, we set up a singlevesicle docking/fusion assay. We immobilize t-SNARE-bearing proteoliposomes (t-vesicles) on the biotin-PEG-coated surface in a flow cell through the streptavidin-to-biotin lipid conjugation. Vesicles carrying VAMP2 (v-vesicles) are then added into the flow cell and vesicle docking is allowed in the absence or presence of A-syn ( Figure 1C ). We first vary the A-syn concentration up to 25 μM. Also, we use an asymmetric acidic lipid distribution on tand v-vesicles (15 mol% PS plus 2 mol% PIP 2 on t-vesicles and 5 mol% PS on v-vesicles, respectively), mimicking a favorable charge distribution for Ca 2+ -triggered vesicle fusion [40, 50] . The results show that at concentrations below 2.5 μM, A-syn promotes vesicle docking by as much as three-fold ( Figure 1D,E) . However, vesicle docking is markedly reduced when the A-syn concentration is increased further (Figure 1D,E) . We also find that A-syn enhances vesicle docking when a major Ca 2+ -sensor syt1 [51] is present on the vvesicle although the effect comes out much smaller due to the fast saturation of docking in the presence of syt1 (Supplementary Figure S1) . Reduced docking and aggregation of vesicles by A-syn have been extensively studied by Diao et al. [21] . Thus, our work is rather focused on a newly discovered promotion of vesicle docking by A-syn at low concentrations.
To address whether A-syn affects the downstream fusion steps after vesicle docking, we perform Ca 2+ -triggered content-mixing experiments. A-syn does not influence the kinetics and the efficiency of content mixing for docked vesicles within experimental errors ( Figure  1F and Supplementary Figure S2) , consistent with the results from Burre et al. [31] . Thus, the results show that A-syn's effect is restricted to the vesicle docking step.
C-terminal domain of A-syn is essential for the promotion of vesicle docking
It has been shown that A-syn interacts with v-SNARE VAMP2 through its polar C-terminal domain [31] . To examine if the A-syn/VAMP2 interaction plays a role in promoting vesicle docking, we prepare the A-syn mutant (amino acids 1-95) that lacks the VAMP2-interacting C-terminal region. This mutant previously abolished the interaction with VAMP2 [31, 34] . We find that the truncated A-syn is not capable of promoting vesicle docking (Figure 2A and Supplementary Figure S1) . Thus, the result shows that the enhancement of docking requires the interaction of A-syn with VAMP2 through its C-terminal region. We also find that the truncated A-syn is not capable of inhibiting vesicle docking at high concentrations as wildtype A-syn is able to do ( Figure 2B ), also suggesting that the A-syn/VAMP2 interaction is essential for the inhibition of vesicle docking, consistent with the results by Diao et al. [21] .
Acidic lipids on the t-SNARE side are essential for the promotion of vesicle docking by Asyn
Based on the membrane-bound structure, A-syn appears to poise as if it interacts with the negatively charged plasma membrane with its basic amphipatic N-terminal region and simultaneously reaches out and grabs VAMP2 on the vesicle through its hydrophilic Cterminal region, whereby it cross-bridges the vesicle and the plasma membrane in trans. We have shown that the interaction between A-syn and VAMP2 is essential for vesicle docking.
We now test if the negatively charged lipids, which are known to be essential for A-syn's membrane binding [52] , are required on t-vesicles to promote vesicle docking. In our aforementioned experiments (Figures 1 and 2) , we used the lipids' composition of 5 mol% PS in POPC for the v-vesicles, and 15 mol% PS and 2 mol% PIP 2 in POPC for the tvesicles. We now ask if the negatively charged lipids on t-vesicles are required for the promotion of vesicle docking by A-syn.
To answer this question, we first prepare t-vesicles of 20 mol% PS and v-vesicles of no PS. As it is shown in Figure 1 , we observe the four-fold enhancement of vesicle docking with 2.5 μM A-syn ( Figure 3A) . However, when PS on t-vesicles is reduced to zero, A-syn becomes inhibited instead of promoting (30% inhibition) ( Figure 3B ). Moreover, when we reverse the charge asymmetry to have t-vesicle of no PS and v-vesicle of 20 mol% PS, we observe significant decrease, as much as a factor of three, of vesicle docking ( Figure 3C ). On the other hand, when we add 20 mol% PS on both sides, we still observe a factor of two enhancement of vesicle docking ( Figure 3D) , showing that PS on the t-vesicle is critical for the promotion of vesicle docking by A-syn. Thus, the results show that A-syn's interaction with negatively charged PS on t-vesicles plays an essential role in promoting vesicle docking.
A-syn is incapable of cross-bridging vesicles in the absence of t-SNAREs
The results suggest that A-syn promotes vesicle docking in VAMP2-and PS-dependent manners. It was also proposed that A-syn may connect the two opposite membranes directly in trans [53, 54] . Therefore, it raises the possibility that A-syn could mediate vesicle docking by itself even in the absence of SNARE complex formation.
To test this possibility, we carry out the vesicle docking assay using the liposomes without tSNAREs or VAMP2 in replacement of the corresponding SNAREs-carrying vesicle. We find that A-syn is not capable of mediating vesicle docking in the absence of SNARE complex formation (Figure 4) . Thus, the results show that A-syn works as a sort of catalyst for SNARE-dependent vesicle docking which assists vesicle docking mediated by SNARE complex formation.
Discussion
On the basis of our results, we propose a hypothetical mechanistic model whereby A-syn cross-bridges vesicle and plasma membranes, which facilitate SNARE-dependent vesicle docking and subsequently, SNARE complex formation ( Figure 5 ). The N-terminal amphipathic and hydrophobic regions (amino acids 1-100) bind to the plasma membrane in a helical conformation with a break in the middle. Acidic phospholipids in the plasma membrane, including highly negatively charged PIP 2, would make A-syn's binding to it favorable. Meanwhile, the hydrophilic C-terminal region (amino acids 101-140) reaches out to the solution phase and interacts with the N-terminal domain of VAMP2, thereby crosslinking the vesicle to the plasma membrane. We present the membrane-bound portion of Asyn to be a predominantly α-helical monomer. Recently, Südhof and co-workers proposed, based on their fluorescence study, that the N-terminal region of A-syn forms oligomers of helical hairpins upon binding to the membrane [55] . In either case, the molecular interactions that govern the A-syn-induced membrane cross-bridging would be the same; membrane binding via the N-terminal domain and trans-binding to VAMP2 via the Cterminal domain. The oligomerization might help A-syn molecules to work cooperatively in stimulating vesicle docking.
We find that in the absence of SNAREs, A-syn is not capable of holding docked vesicles stably (Figure 4) . Thus, we speculate that the cross-bridging of two membranes by A-syn is weak and perhaps transient. Yet, it is sufficient to facilitate SNARE complex formation, which would accelerate SNARE-dependent vesicle docking.
The idea of cross-bridging of the synaptic vesicle to the plasma membrane mediated by Asyn has been previously put forth by Snead and Eliezer [54] . However, their proposed molecular mechanism is quite different from ours. In their model, the N-terminal amphipathic region of A-syn binds to the plasma membrane, whereas the C-terminal hydrophobic core region interacts in trans with the vesicle membrane [53] . In contrast, our mechanistic model proposes the critical role of the specific interaction between A-syn and VAMP2 in vesicle binding.
There is evidence, both in vivo and in vitro, that A-syn has the capability of mediating clustering of vesicles [21, 22] . Roy and coworkers showed that the metastable or transient tetrameric species might be involved in this process [22] . Then, the mechanism underlying vesicle clustering might be fundamentally different from our mechanistic model for the promotion of vesicle docking by A-syn ( Figure 5 ).
We observed the inhibition of vesicle docking by A-syn when PS was removed from tvesicles ( Figure 3) . The results might suggest that the A-syn-mediated attraction among vvesicles is in competition with the A-syn-mediated attraction between v-and t-vesicles. Thus, when PS is removed from t-vesicles, the attraction among v-vesicles induced by A-syn surpasses the attraction between t-and v-vesicles, because A-syn no longer has the affinity to the t-vesicle membrane. This would result in reduced vesicle docking.
Although A-syn has the ability to promote vesicle docking, it does not change the efficiency or the kinetics of SNARE-dependent fusion pore opening among docked vesicles ( Figure  1F ), consistent with the results from electrophysiological measurements of cultured neurons [31, 56] . Our results show that A-syn is likely to be involved in vesicle docking step prior to membrane fusion. For example, A-syn potentially plays a role in effectively replenishing the readily releasable pool of vesicles. The measurement of the rates of docking with the singlevesicle docking assay would provide further insights into A-syn's role in vesicle trafficking.
In this work, we have examined the effect of A-syn on docking of two equally sized proteoliposomes of ~90 nm [36] . In reality, synaptic vesicles are smaller, whereas the plasma membrane is flatter than the proteoliposomes. Because A-syn has the preferred affinity to the highly curved membranes [57] , the hypothetical cross-bridging of synaptic vesicles to the plasma membrane might be somewhat weaker than what has been observed in our in vitro study, warranting further work.
In summary, A-syn is structured in such a way that it could interact with the membrane via the amphipathic N-terminal region and concurrently with VAMP2 on the opposite membrane. The results suggest that such a cross-bridging could be the mechanism whereby A-syn promotes SNARE complex formation and vesicle docking.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Histograms of docking probabilities without (−A-syn) or with 2.5 μM A-syn (+A-syn) using t-vesicles containing 20 mol% DOPS and v-vesicles without DOPS (t20/v0) (A), both t-and v-vesicles without DOPS (t0/v0) (B), t-vesicles without DOPS and v-vesicles containing 20 mol% DOPS (t0/v20) (C), and both t-and v-vesicles containing 20 mol% DOPS (t20/v20) (D). Error bars denote the SD of three independent experiments, and movies recorded from more than five randomly selected screens were analyzed and averaged in each experiment. A-syn adsorbs to the surface of the plasma membrane through its N-terminal region and concurrently interacts with the VAMP2 on synaptic vesicles through its C-terminal region, thereby cross-bridging the synaptic vesicles with plasma membrane, which facilitates the SNARE complex formation that in turn stabilizes the docked vesicle.
